Anavex Life Sciences Corporation【AVXL】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update

Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex...

Anavex Life Sciences to Announce Fiscal 2025 First Quarter Financial Results on Wednesday, February 12, 2025

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:...

Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:...

Form 4 - Statement of changes in beneficial ownership of securities

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease

Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy...

New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

Topline ATTENTION-AD trial: Patients showed improved cognition and function over three years Delayed-start...

Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference

Topline data from ATTENTION-AD Open-Label-Extension (OLE) 96/144-Week trial J.P. Morgan 2025 Healthcare...

georgejjl 2時間前

Good luck and GOD bless,

👍️0

georgejjl 2時間前

9 years and counting

An Australian TV news interview of Ern Heaven and his wife. Ern had Alzheimer's for over 2 years and was declining when he joined the Anavex phase 2a trial of Anavex 2-73. Over a period of a year on the drug, he first stabilized, and then improved. No other drug has ever helped an Alzheimer's patient improve.

According to the 1 year trial results, 6 patients out of the initial 32 had "strong" reactions and showed improvements in one or more tests.

Good luck and GOD bless,

👍️ 1

mauismart 2時間前

The golden age of innovation when it comes to finding therapies for alzheimers is not too far away. Just ask the patients who have been on blarcamesine.

👍️ 3 💯 1

mauismart 2時間前

I bought a bunch of april 9 dollar calls for.86 today. I think we hold above 9 bucks soon. 10 dollars is not far off either. Go avxl.

👍️ 2

mauismart 2時間前

The short bashers have changed the topic here. They are not focusing on the fact that avxl is up today and they are replying to each other.

👍️ 4

meds4life 3時間前

Waste and corruption? Look into the military procurement budget and tax laws that favor big campaign donors!

👍️ 2

boi568 3時間前

I agree with everything you said, except for that the fact that the House under Clinton passed that budget with one vote to spare, and it was not a bipartisan majority. The key vote was cast by a Representative who paid for it with her seat in the next election.

👍️ 1

falconer66a 4時間前

Blarcamesine and 3-71 Will Solve U.S. Deficits

Actually, when blarcamesine, Anavex 3-71, and the other drugs in the Anavex pipeline get approved for all of the anticipated indications, and especially when everyone takes a daily Anavex pill to maintain continuing good health, health care and medical costs will plunge dramatically; so much that our annual federal budget deficits will evaporate. Trillions upon trillions of dollars will be saved.

[Of course, offered to keep things light; a bit of off-putting sarcasm....]

🎯 2 👍️ 5

baltimorebullet 4時間前

This is the only social media platform I'm on.
Because of Anavex of course.
And all of you who must share your precious opinions on off topic subjects have managed to ruin this too.
Do you not have anywhere else to show off your keen insights?
I'm guessing not.
Do you not wonder why?

👍️ 5

LakeshoreLeo1953 4時間前

Gov’t revenues have increased (except ‘09-‘11 and Covid) even given
Tax Legislation. An inability to prioritize “needs” and…IMHO… the fallacy of taxing earnings not consumption are MUCH more to blame.

👎️ 1 👺 2

rx7171 4時間前

Note in your commentary the deficit problem is largely a function of massive tax cuts benefiting primarily the wealthy under Republican presidents.
Reagan, Bush the lesser and Trump.

Yet that party constantly screams about the deficit when Democrats are in office demanding it should be solved by slashing programs benefiting average Americans. 🤷‍♂️

👍️ 6

Hoskuld 5時間前

This is probably not the right forum, but the deficit problem is solvable. We have to attack it the same way we did rebuilding Europe with the Marshal Plan post-WW2: we tax ourselves at a high rate and pay it down. The annual deficit is something that ballooned from 350b at the end of the Obama administration to $2T under Trump (average,. not peak.) Trump is no deficit-slayer.

We should cut the fat out of the budget. That fat is not in foreign aid or food stamps - anything found there is minimal. The big fat is in the defense budget. But defense is important, and most of us think the waste there (within reason) is OK. Still, the only way to close the budget is to tax. We had a balanced budget as recently as the late 90s under Clinton (with a Republican-controlled house of reps that was acting in the best interests of the country.) Then we cut, cut, and cut taxes more (and started 3 wars at the same time) and the deficit ballooned in step-wise increases - under Bush...then was chipped away at for 8 years under Obama...then ballooned massively under Trump. The lesson should be: we have to pay for our security, health, and infrastructure. There are no free rides.

We Americans need to band together and take up the challenge of paying down our debt and building again. This is what it means to be good stewards of a great legacy. Greed has clouded our minds and we need to clear them.

👍️ 5 👎️ 4 👺 1

williamssc 5時間前

True a lot of retirees in Florida. I have read there's also a lot of fraud with doctors billing.

👍️ 5 👎️ 1 👺 1

boi568 5時間前

"DOGE," a collection of youngsters recruited by Elon Musk, is neither a government department lawfully empowered to impound Congressionally appropriated activities, nor effective in rooting out "waste" in these programs. Musk just wants to call programs he doesn't agree with "waste" so he can unconstitutionally kill them.

👍️ 11 👺 4 💯 5

williamssc 5時間前

Probably so. Like me in retirement I don't make what I did as a working engineer. Retirement income replaced with social security and a pension if your so lucky. I'm one of the luck ones. My wife and I live like my parents did just enjoying life, freezing and canning and going to church. Living frugal. Our carbon foot print is a baby step. lol

👍️ 5

falconer66a 5時間前

Medicare Costs and Blarcamesine
And the cheapest solution potentially available, blacarsamine, [to treat Alzheimer's] will benefit if there was belt-tightening.
As we know, increasing numbers of the elderly are succumbing to Alzheimer's disease each year. They all will need treatment; which in the U.S will involve Medicare or other government funding sources.

The existing Alzheimer's treatments, the FDA-approved monoclonal antibody drugs, Leqembi, etc., are extremely expensive. Blarcamesine won't be. The cost difference will be a powerful driver for blarcamesine approval and utilization; across the Western world. Government medical insurance agencies save lots and lots of money. Patients do, too. And, blarcamesine is far easier and convenient to take, a single pill a day. No need to be taken to a radiology center to get periodic brain scans to check for brain hemorrhaging or shrinkage. Most importantly, blarcamesine will exhibit far better treatment outcomes.

Blarcamesine, and Anavex (and its shareholders) will win.

🎯 3 👍️ 16 💯 2

boi568 5時間前

I would expect a lot of payments to go to such a large state known for the size of its retired population.

👍️ 2 💯 1

Bourbon_on_my_cornflakes 5時間前

Of course they are not talking about it. You do financial stuff; do the math.

Here's "the math". The USA cannot afford to keep borrowing 33 cents of every dollar spent, $2 Trillion plus a year, without a financial reckoning that will make Medicare funding a minor issue. The country is not in a recession, the budget should be balanced not at record deficits. And increasing taxes 50% would crater the economy. So the only solution is to cut out the massive waste and fraud and featherbedding that DOGE is finding.

🎯 3 👍️ 13 👎️ 1 👺 1

mike_dotcom 5時間前

Rick Scott could probably tell you all about it.

👍️0

kund 5時間前

WGT is talking about Medicare and Anavex—it's like putting the cart before the horse. The moron CEO isn’t even talking to the FDA. He first needs to schedule a Type B meeting with the agency and come up with a plan for NDA filing. Even if he starts today, it will take more than a year for an FDA decision. So lay down your pipe and get back to reality.

👍️ 1 👎️ 1 👺 2

Bourbon_on_my_cornflakes 5時間前

Correct. Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core.

With "Advantage" plans, the insurer decides if you get treatment. So if you have cancer and are 85, they could say it is not cost-effective to treat you, go die. Kind of like what the original Obamacare was about with Dr. Ezekiel Emmanuel. Death panels doing economics analysis.

Get supplementary medicare insurance where you and the doctor make the decision on treatment, not an economist.

👍️ 5

Hoskuld 5時間前

2-73 should be covered by Medicare part D - and part D premiums are based on income. Do you agree?

👍️ 1 👎️ 1 👺 1 😁 1

williamssc 5時間前

It's a big problem that needs solved perhaps better software to catch it. A lot of payments seem to go to Florida.

LakeshoreLeo1953 5時間前

You ARE kidding about Medicare premium pricing?
Do just a bit of investigating.
Sight unseen I would take your premium.

👍️ 1

Hoskuld 5時間前

Of course, the big value driver is product approval.

👍️ 2

Bourbon_on_my_cornflakes 5時間前

more silliness

Yes, and if the Medicare program isn't funded as well in the future there would be no getting around the shrinking of the AD market in the United States.

Bedtime stories donkeys use to scare their parents.

🏆️ 3 👍️ 3 👎️ 2 👺 1 🤣 1

williamssc 5時間前

I hope they cut out fraudulent payments BEFORE they go out. Wouldn't that be something. Medicare loses Billions to fraud.

🎯 4 👍️ 5 👎️ 1 👺 1

boi568 5時間前

Of course they are not talking about it. You do financial stuff; do the math.

"[N]o one is talking about cutting Medicare, just the fraud so there is enough money for real patients."

👍️ 5 👎️ 1 🙄 1

Bourbon_on_my_cornflakes 5時間前

Incorrect and silly statement

Yes, investors here should keep an eye on the political threat to Medicare and Medicaid, since those are critical insurers in the event of FDA approval of blarcamesine and an ultimate source of a great deal of revenue for us in the U.S. Alzheimer's market.

There is no threat to Medicare, in fact rooting out the fraud and corruption is necessary to protect them. And the cheapest solution potentially available, blacarsamine, will benefit if there was belt-tightening.

🎯 2 👍️ 4 👎️ 2 👺 1 🤣 1

Bourbon_on_my_cornflakes 5時間前

you're trying too hard 😄

The only thing that would affect AVXL is the EMA approval. Period. Tariffs mean nothing for a business with no revenues, working on a product that is a medical need, not a discretionary purchase. And no one is talking about cutting Medicare, just the fraud so there is enough money for real patients.

🎯 3 👍️ 4 👎️ 1 👺 1

dia76ca 5時間前

AVXL can certainly be a Safe Haven Investment. But it will be affected by the general market. Volumes should be much higher. The share price should already be multiples of the current price!
However there are powerful catalysts in coming months.
1. More long term trial (OLE) information.
2. Anavex 3-71 phase 2b Schizophrenia trial results.
3. Partnerships for Europe, the UK, Canada and Australia and Asia
4. European approval for blarcamesine.
5. FDA discussions leading to priority review.
There is a worldwide need for blarcamesine and Anavex 3-71. That need will only increase with time.
Follow the science!

👍️ 4 😀 1

williamssc 5時間前

Medicare premiums are the same for the "less wealthy". Many may not know this but government premiums have risen $30.00 a month for everyone on medicare just to pay the "mab" costs. I'm hoping when Blarcamesine is approved costs will revert back. Hope springs eternal. Praying for a good outcome for medicare folks and everyone else.

👍️ 4 😀 1

plexrec 6時間前

Jonjones--"You never know."--long time no hear from you---good to see you are still around--our day coming soon !!!!

👍️ 1

Hoskuld 6時間前

Since you are here on a stock message board, you are probably wealthy. But many are not - and that is when the government and insurance steps in. Undermine that system and the upside lowers.

👍️ 1 💯 1

poguemahone 6時間前

Cool the engines….one day does not a trend make.

👍️0

falconer66a 6時間前

AVXL as a Safe Haven Investment?

Ok, how might a typical, general stock investor perceive things when the stock indices all continue to descend, but the AVXL share price continues to ascend?

Stock investors do their D.D., due diligence (which is, really, their "determining diligence"). What will potential new AVXL investors find when they search around for the reasons the AVXL share price is rising, contrary to the declining trends of the stock indices?

Will potential new AVXL buyers see that Anavex science is becoming validated, and large drug sales will begin, especially when the European Medicines Agency approves blarcamesine for Alzheimer's?

Shortly, will Anavex Life Sciences Corp be a safe haven investment in an otherwise declining equity market? Let's watch.

👍️ 11 😀 1

georgejjl 6時間前

Expect over 1 million AVXL shares to be bought today!!!

Good luck and GOD bless,

👍️0

boi568 6時間前

Medicare advantage is not government Medicare. People should avoid these plans which look good up front but provide less at their core. Medicare is run much more leanly than for-profit Medicare advantage plans. However, they all would suffer if Medicare is cut, including any coverage of AD prescriptions.

👍️ 6

boi568 6時間前

Yes, and if the Medicare program isn't funded as well in the future there would be no getting around the shrinking of the AD market in the United States.

👍️ 1

rx7171 6時間前

Congress created the Advantage option for Medicare at the behest of the insurance industry to get a chance to make profits from Medicare recipients.
They make profits by minimizing care through procedural run arounds and paperwork.

I ‘m very happy with my regular Medicare since it is not driven by a profit motive.
No run around getting coverage when needed.

🎯 1 👍️ 6

aredrooster 6時間前

Anavex news... like a box of chocolates ... and so on.

👍️ 2 😃 1

georgejjl 7時間前

How many people expect news regarding Anavex this week???

Good luck and GOD bless,

👍️0

Investor2014 7時間前

Cancer indications - yes!

👍️0

williamssc 7時間前

Medicare advantage has been eroding for years now, they are paying less and less while raising the out of pocket and now most want you to get a referral. Jerking old people around is what they do best. Congress needs to kick these insurers in the keester.

👍️ 7

LakeshoreLeo1953 7時間前

“List Price” of Rx for the retired is a fallacy.
However, $10K/yr premiums and 3-5K deductible is a reality per couple.
Factor in Dental and Vision…you best be prepared for retirement.

Of course those able to gamble in pre revenue bio shouldn’t worry…..

👍️ 1 👎️ 1 👺 1

Steady_T 7時間前

Drugs are covered by Part D plans. Every Medicare recipient chooses which plan they want to enroll in. Each plan has different drugs that it will pay for and those are chosen by the private plans.

👍️ 1

williamssc 7時間前

I like most elderly on medicare pay for our meds. My supplemental prescription plan helps but I still pick up my portion. These plans are not cheap and on top of monthly medicare costs. I don't know anyone getting anything cheap.

👍️ 7

Jonjones325 7時間前

Just doing a little AI searching. Companies can and have been approved after clock stop 1.

You never know.

👍️ 11 😃 2

Hoskuld 7時間前

If approved, then 2-73 will be a winner.

👍️ 5

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター